Focus Partners Advisor Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.5M Buy
145,419
+23,735
+20% +$621K 0.03% 256
2026
Q1
$3.42M Sell
121,684
-75,984
-38% -$2.02M 0.03% 241
2025
Q4
$4.92M Buy
197,668
+41,885
+27% +$1.06M 0.06% 150
2025
Q3
$3.92M Buy
155,783
+6,526
+4% +$161K 0.04% 213
2025
Q2
$3.62M Buy
149,257
+4,686
+3% +$109K 0.05% 177
2025
Q1
$3.66M Buy
144,571
+20,225
+16% +$529K 0.06% 161
2024
Q4
$3.3M Buy
124,346
+21,519
+21% +$584K 0.06% 158
2024
Q3
$2.98M Buy
102,827
+10,673
+12% +$311K 0.06% 142
2024
Q2
$2.58M Buy
92,154
+13,367
+17% +$368K 0.07% 142
2024
Q1
$2.19M Buy
78,787
+45,667
+138% +$1.27M 0.06% 152
2023
Q4
$954K Sell
33,120
-32,287
-49% -$976K 0.05% 175
2023
Q3
$2.17M Buy
65,407
+37,883
+138% +$1.34M 0.11% 93
2023
Q2
$1.01M Buy
27,524
+2,011
+8% +$78.3K 0.06% 133
2023
Q1
$1.04M Sell
25,513
-1,434
-5% -$61.9K 0.07% 123
2022
Q4
$1.38M Sell
26,947
-20,990
-44% -$1.01M 0.11% 104
2022
Q3
$2.1M Buy
47,937
+19,022
+66% +$924K 0.12% 84
2022
Q2
$1.52M Buy
28,915
+7,174
+33% +$366K 0.13% 83
2022
Q1
$1.13M Buy
+21,741
New +$1.13M 0.11% 105

Other funds holding PFE

Focus Partners Advisor Solutions's PFE Position: Q2 2026 in Review

Focus Partners Advisor Solutions increased its Pfizer (PFE) stake by 20% in Q2 2026, buying an estimated $621K and bringing the position to 145,419 shares worth $3.5M. The position accounts for 0.03% of the portfolio, ranked #256.

Focus Partners Advisor Solutions first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.92M in Q4 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Focus Partners Advisor Solutions held 145,419 shares of Pfizer worth $3.5M as of Q2 2026.
  • Focus Partners Advisor Solutions bought 23,735 Pfizer shares in Q2 2026, an estimated $621K.
  • Pfizer made up 0.03% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #256 holding.
  • Focus Partners Advisor Solutions first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Focus Partners Advisor Solutions's Pfizer position peaked at $4.92M in Q4 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.